Skip to main content

$0.670 -0.035 (-4.97%)

High

$0.71

Low

$0.67

Trades

144

Turnover

$499,806

Volume

735,349
30 June 2023 at 4:10pm
Register to track 4DX and receive email alerts.
Subject
4DX Ann: Chairman's Address to Shareholders

4DX Ann: Quarterly Activity Report and Appendix 4C for Q1 FY2022

4DX Ann: 2021 Notice of Annual General Meeting

4DX Ann: Appendix 4G and Corporate Governance Statement

4DX Ann: 2021 Annual Report

4DX Ann: 4DMedical advances Australian clinical pilot with I-MED

4DX Ann: 2021 Annual General Meeting

4DX Ann: FY21 Full Year Results

4DX Ann: Appendix 4E - Preliminary Final Report

4DX Ann: Change in substantial holding

4DX Ann: Change of interests of substantial holder - Velocimetry & HF

4DX Ann: Change of interests of substantial holder - 4DMedical

4DX Ann: 4DMedical secures contract with pharmaceutical company

4DX Ann: Application for quotation of securities - 4DX

4DX Ann: Release of restricted securities from escrow

4DX Ann: 4DMedical to present at NWR virtual investor conference

4DX Ann: 4DMedical Investor Conference Presentation - July 2021

4DX Ann: Quarterly Activity Report and Appendix 4C for Q4 FY2021

4DX Ann: Application for quotation of securities - 4DX

4DX Ann: Cleansing Notice

4DX Ann: 4DMedical Tax Exempt Employee Share Plan Rules

4DX Ann: 4DMedical commences XV LVAS clinical trial at Johns Hopkins

4DX Ann: Notification regarding unquoted securities - 4DX

4DX Ann: 4DMedical receives US$600k order for preclinical scanner

4DX Ann: Change of interests of substantial holder - Velocimetry & HF

4DX Ann: Change of interests of substantial holder - AF

4DX Ann: Change of interests of substantial holder - 4DMedical

4DX Ann: 4DMedical commences patient recruitment for VQ trial

4DX Ann: 4DMedical partners with RCI for clinical pilot program

4DX Ann: Quarterly Activity Report and Appendix 4C for Q3 FY2021

4DX Ann: 4DMedical Goldman Sachs Healthcare Forum Presentation

4DX Ann: Appendix 3Y - BR

4DX Ann: Appendix 3Y - LG

4DX Ann: Appendix 3Y - LB

4DX Ann: Appendix 2A

4DX Ann: Update - Proposed issue of Securities - 4DX

4DX Ann: 4DMedical raises $6m in strongly supported SPP

4DX Ann: 4DMedical secures streamlined access to US DoD&VA contracts

4DX Ann: 4DMedical to present at NWR virtual investor conference

4DX Ann: Appendix 3G

4DX Ann: Share Purchase Plan Offer Booklet

4DX Ann: Becoming a substantial holder

4DX Ann: S&P DJI Announces March 2021 Quarterly Rebalance

4DX Ann: Appendix 2A

4DX Ann: Cleansing Notice

4DX Ann: Proposed issue of Securities - 4DX

4DX Ann: Award of MRFF Frontier grant & capital raising presentation

4DX Ann: Reinstatement to Official Quotation

4DX Ann: 4DMedical successfully completes A$40m placement

4DX Ann: 4DMedical-led consortium awarded $28.9m MRFF grant

Register to track 4DX and receive email alerts.

Similar Companies

ALC
CGS
IME
M7T
MDR
PCK
PKS
PME
RAP